TTAV is experiencing heavy censorship on many social media channels since we’ve been targeted by the mainstream media sellouts, social media bullies, and political turncoats. Be sure to get the TRUTH by subscribing to our email list. It’s free.
On September 11, 2023, in an unexpected and far-reaching decision, the CDC’s Advisory Committee on Immunization Practices (ACIP) unveiled a recommendation that has become the epicenter of heated debate. The ACIP’s proposal of untested COVID boosters for everyone aged six months and upwards is not only audacious but also riddled with complexities, unanswered questions, and a growing chasm of public mistrust.
The Current State of Jab Administration
Harvey Risch, M.D., Ph.D., professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health critiqued the continual push for updated COVID-19 shots, underscoring the growing skepticism in the scientific community. He categorically labeled the notion of these new jabs as “a useless idea.” Most of the population, having either contracted the virus at least once or having received a shot, has some degree of exposure. So why the push for another shot, especially when it’s untested? The skepticism is deepened by CNBC’s revealing statistic: a mere 17% uptake for Pfizer’s and Moderna’s earlier jabs launched in September 2022. Such low numbers in the past beg the question: What can we expect from another round?
Nursing homes, which house some of the most vulnerable members of our society, have shown surprisingly low uptake of these jabs. Medicare’s data shows that only about 62% of residents are “up to date” with their shots.
Even the most vulnerable don’t trust these pseudoscientific experiments.
Pushing an untested booster into this scenario seems not just premature but potentially perilous. With previous shot updates not being wholly embraced, is it responsible to introduce another layer, especially one that’s uncharted?
Growing Public Sentiment & Distrust
The population’s wariness towards these jabs has roots in a range of concerns. A revealing survey from Vaccine shed light on this hesitancy: many abstain from jabs due to existing immunity from prior infections, while others are wary of side effects and doubts about the protective benefits. But these aren’t the only worries. Reports of post-jab health anomalies, such as a surge in healthy individuals developing serious health conditions and unexplained sudden deaths, cannot be overlooked. When these real-world experiences are combined with Freedom of Information Act-obtained documents indicating a majority of COVID-19 hospitalizations are among those who received the shots, trust in the system plummets.
Dr. Robert Malone, pioneer and expert in mRNA and DNA vaccines and therapies holds a perspective on the current scenario that provides a sobering lens. Drawing a comparison between weekly COVID fatalities and the alarming daily death rate from opioids, particularly among the young, shifts the focus.
While there are “271 deaths per week … with COVID … we lose 200-300 mostly young people per day to Fentanyl and other opiates,” Malone wrote.
Are we, as a society, directing our energies and resources effectively? By spotlighting COVID-19, are we sidelining equally pressing health crises?
The Novavax Conundrum
Novavax’s journey in this pandemic offers another perspective on the broader shot narrative. The delay in FDA approval for Novavax, despite its reliance on longstanding protein-based technology, has raised eyebrows. Dr. Risch has posited a troubling potential reason for this delay: the sway of financial contributions over health decisions. This seriously undermines trust in our regulatory systems. Are financial interests eclipsing the genuine health concerns of the populace? Are the industries designed to protect us putting profits over patients?
The Biden administration’s recent endorsement of simultaneous administration of different jabs—COVID-19, flu, and RSV—pushes us into a realm of the unknown. Linda Wastila, Ph.D., professor of geriatric pharmacotherapy at the University of Maryland School of Pharmacy and director of research for the Peter Lamy Center for Drug Therapy and Aging, has rightfully emphasized the severe lack of real-time studies assessing the concurrent use of these jabs. Without comprehensive data, can we responsibly endorse such an approach?
The motivations behind these massive shot drives are becoming increasingly blurred. Moderna’s recent statements to its investors, emphasizing the increase of jab sales via “awareness campaigns,” hints at potential profit-driven motives. If these corporate giants are pushing for shot uptake primarily to increase sales and profitability, where does that leave public health?
Expert Opinions & Ethical Considerations
Physicians, scientists, and health experts have long been guided by a simple oath: ‘Do No Harm.’ However, the current landscape, as described by Dr. Pierre Kory, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), makes one question if this principle is being upheld. Without adequate knowledge of the long-term effects of these jabs and the potential repercussions of their combined administration, advising or endorsing them becomes ethically questionable.
In an era where every individual seeks protection and a return to normalcy, it’s vital to ensure that decisions made are grounded in robust science, devoid of external financial influences, and made with the genuine well-being of the public in mind. The growing skepticism and questions surrounding the continual introduction of new jabs, especially untested ones, underscore the need for transparency, accountability, and genuine concern for public health above all else.
Follow, Subscribe, & SHARE:
1. X, Formerly known as Twitter: https://twitter.com/TTAVOfficial
2. Telegram: https://t.me/TheTruthAboutCancer_Vaccines
4. GETTR: https://gettr.com/user/cancertruth
5. TruthSocial: https://truthsocial.com/@TheTruthAboutCancer
7. Bitchute: https://www.bitchute.com/channel/vX3lcHH4Dvp0/
9. Brighteon: https://www.brighteon.com/channels/thetruthaboutcancer